Diosmetin as a Promising Anticancer Agent: Mechanisms, Structural Optimization, and Advanced Delivery Systems
ACS Omega · 03.11.2026 · 11 (43) · 65930-65947
DOI: 10.1021/acsomega.6c03859 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Omega, online erschienen am 20.10.2026. Verfasst von Lin Long und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Center I Department, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao 266000…. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Qingdao Science and Technology Benefiting the People Demonstration Project, Shandong Province Key Traditional Chinese Medicine Science and Technology Project, Medical and Health Scientific Research Project of Qingdao.
Abstract (Originalsprache)
Diosmetin (Dio) is a natural flavonoid with broad-spectrum anticancer activity against various malignancies through mechanisms involving cell cycle arrest, apoptosis induction, metastasis inhibition, and modulation of oncogenic signaling pathways such as STAT3/c-Myc and PI3K/AKT/mTOR; with the exception of CDK2, which has been proposed as a direct target in esophageal squamous cell carcinoma, no other direct molecular targets of diosmetin have been identified to date. It also exhibits synergistic efficacy with reduced toxicity when combined with radiotherapy or chemotherapy. However, clinical translation is severely hampered by poor water solubility, low bioavailability, and unidentified direct molecular targets. Structural modifications (esterification, etherification, phosphorylation) and advanced drug delivery systems (SMEDDS, targeted liposomes, composite nanoparticles) offer promising strategies to overcome these limitations. This review provides an integrated framework covering the complete chain from extraction and chemical derivatization to formulation strategies and anticancer mechanisms, with critical analysis of current translational bottlenecks, particularly the disconnect between in vitro and in vivo findings. By integrating chemical optimization with pharmacological mechanisms, this review aims to provide a theoretical foundation to inform and guide future preclinical and translational research on Dio as a potential adjunct to existing cancer therapies. While some of these strategies have been validated in cancer models, others have been demonstrated in noncancer settings and await translation to oncology.
Autor:innen und Institutionen
- Oncology Center I Department, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao 266000, China.
- The First Clinical College of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China.
- Department of Cardiothoracic Surgery, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao 266000, China.
- Qingdao Key Laboratory of Biomacromolecular Drug Discovery and Development, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.
ORCID-Profile: Chuanlong Guo
Förderung
- Qingdao Science and Technology Benefiting the People Demonstration Project
- Shandong Province Key Traditional Chinese Medicine Science and Technology Project
- Medical and Health Scientific Research Project of Qingdao
- The Training Project of Qingdao Medical
- Health Talents and Qingdao Key Laboratory of Biomacromolecular Drug Discovery and Development
Zitieren
APA
Long, L., Liu, Y., Zang, J., Lin, G., Guo, C., & Xiao, J. (2026). Diosmetin as a Promising Anticancer Agent: Mechanisms, Structural Optimization, and Advanced Delivery Systems. ACS Omega, 11(43), 65930-65947. https://doi.org/10.1021/acsomega.6c03859
Vancouver
Long L, Liu Y, Zang J, Lin G, Guo C, Xiao J. Diosmetin as a Promising Anticancer Agent: Mechanisms, Structural Optimization, and Advanced Delivery Systems. ACS Omega. 2026;11(43):65930-65947. doi:10.1021/acsomega.6c03859
BibTeX
@article{Long2026,
author = {Long, Lin and Liu, Yuning and Zang, Jianhua and Lin, Gaoyang and Guo, Chuanlong and Xiao, Jun},
title = {Diosmetin as a Promising Anticancer Agent: Mechanisms, Structural Optimization, and Advanced Delivery Systems},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {43},
pages = {65930--65947},
doi = {10.1021/acsomega.6c03859}
}
EUVIMED